Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic problems in controlled trials.

R Burkhardt, G Kienle

    Journal of Medical Ethics
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Methodological inconsistencies in drug trials raise ethical and legal issues, particularly in Germany. Physician judgment of drug efficacy faces significant limitations, impacting controlled trial feasibility.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    BioXmark for high-precision radiotherapy in an orthotopic pancreatic tumor mouse model : Experiences with a liquid fiducial marker.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2017
    Same author

    [Chronic Obstructive Pulmonary Disease (COPD) - Rational Diagnostics and Therapy].

    Pneumologie (Stuttgart, Germany)·2016
    Same author

    [PCSK9 - "missing link" in familial hypercholesterolemia : New therapeutic options in hypercholesterolemia and coronary artery disease].

    Herz·2016
    Same author

    Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.

    Leukemia·2010
    Same author

    Role of flap tension in primary wound closure of mucoperiosteal flaps: a prospective cohort study.

    Clinical oral implants research·2010
    Same author

    Soft tissue dehiscence coverage around endosseous implants: a prospective cohort study.

    Clinical oral implants research·2008
    Same journal

    Ethics briefing.

    Journal of medical ethics·2026
    Same journal

    Medical ethics and categorisation.

    Journal of medical ethics·2026
    Same journal

    Suspension or prioritisation? Exploring the ethics of age-based rationing in adult ADHD services.

    Journal of medical ethics·2026
    Same journal

    Ethics of not knowing who we are talking to in qualitative research.

    Journal of medical ethics·2026
    Same journal

    Suicide is not a public health issue and perhaps very few things should be.

    Journal of medical ethics·2026
    Same journal

    Normalising transparency: an argument for requiring generative AI use declarations in all manuscripts-with a call for commentaries.

    Journal of medical ethics·2026
    See all related articles

    Area of Science:

    • Medical ethics
    • Clinical trial methodology
    • Pharmaceutical law

    Background:

    • Recent critical discussions in Germany have highlighted issues with controlled trials.
    • The experimental approach to drug efficacy assessment presents inherent methodological challenges.

    Purpose of the Study:

    • To discuss methodological, ethical, and legal problems associated with controlled trials.
    • To analyze the limitations imposed on controlled trials in Germany.

    Main Methods:

    • Critical review of existing discussions on controlled trials.
    • Analysis of ethical and legal considerations in drug efficacy assessment.

    Main Results:

    • Methodological inconsistencies necessitate physician judgment of drug efficacy.
    Keywords:
    Biomedical and Behavioral Research

    Related Experiment Videos

  • This reliance on physician judgment creates significant ethical and legal challenges in Germany.
  • These challenges considerably limit the feasibility of conducting controlled trials within Germany.

    • Conclusions:

    • Controlled trials in Germany face substantial ethical and legal hurdles.
    • Physician-based efficacy judgment, while necessary, complicates trial design and execution.
    • Further consideration of these issues is required to navigate the complexities of clinical trials.